Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
Teva
Johnson and Johnson
Express Scripts
UBS

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 10,370,374

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,370,374
Title:Heterocyclic compounds and uses thereof
Abstract: Provided herein are heterocyclic compounds of Formula (I), pharmaceutical compositions containing such a compound and their therapeutic uses, methods for their preparation, intermediate compounds, pharmaceutical compositions containing such a compound, and their therapeutic uses.
Inventor(s): Ibrahim; Prabha N. (Mountain View, CA), Spevak; Wayne (Berkeley, CA), Zhang; Jiazhong (Foster City, CA), Shi; Songyuan (Fremont, CA), Powell; Ben (Pleasant Hill, CA), Ma; Yan (Belmont, CA)
Assignee: Plexxikon Inc. (Berkeley, CA)
Application Number:15/977,772
Patent Claims:see list of patent claims

Details for Patent 10,370,374

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Try a Free Trial Plexxikon Inc. (Berkeley, CA) 2035-09-21 RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Try a Free Trial Plexxikon Inc. (Berkeley, CA) 2035-09-21 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Try a Free Trial Plexxikon Inc. (Berkeley, CA) 2035-09-21 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07   Try a Free Trial Plexxikon Inc. (Berkeley, CA) 2035-09-21 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07   Try a Free Trial Plexxikon Inc. (Berkeley, CA) 2035-09-21 RX Orphan search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07   Try a Free Trial Plexxikon Inc. (Berkeley, CA) 2035-09-21 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
McKesson
Cipla
Teva
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.